Ftse Mib
33.294,96
0,00%
DAX
19.146,17
0,76%
S&P 500
5.948,71
0,53%
NASDAQ
18.972,42
0,03%
Bitcoin
98.872,92
0,36%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Insmed Inc (INSM) Insmed Inc (INSM) Notizie

Insmed Inc

INSM
73,81
1,14 (1,57%)
22 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/11/202414:00EDGAR2Form 8-K - Current report
07/11/202414:00PRNUSInsmed Reports Inducement Grants Under NASDAQ Listing Rule..
06/11/202414:00PRNUSInsmed To Present at November 2024 Investor Conferences
31/10/202412:00EDGAR2Form 8-K - Current report
31/10/202412:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202412:00PRNUSInsmed Reports Third-Quarter 2024 Financial Results and..
24/10/202422:05PRNUSInsmed Ranks No. 1 on Science's 2024 Top Biopharma Employers..
23/10/202414:00PRNUSInsmed Unites Across Communities Around the World During..
17/10/202414:00PRNUSInsmed to Host Third-Quarter 2024 Financial Results..
08/10/202422:05PRNUSNew Subgroup Analyses from Landmark Phase 3 ASPEN Study of..
04/10/202414:00PRNUSInsmed Reports Inducement Grants Under NASDAQ Listing Rule..
16/9/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:28EDGAR2Form 144 - Report of proposed sale of securities
11/9/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:14EDGAR2Form 144 - Report of proposed sale of securities
10/9/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:19EDGAR2Form 144 - Report of proposed sale of securities
06/9/202414:00PRNUSInsmed Reports Inducement Grants Under NASDAQ Listing Rule..
03/9/202423:22EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
03/9/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202421:57EDGAR2Form 144 - Report of proposed sale of securities
14/8/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202422:05EDGAR2Form 144 - Report of proposed sale of securities
12/8/202422:01EDGAR2Form 144 - Report of proposed sale of securities
09/8/202423:30EDGAR2Form 8-K - Current report
08/8/202413:00EDGAR2Form 8-K - Current report
08/8/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:00PRNUSInsmed Reports Second-Quarter 2024 Financial Results and..
02/8/202414:00PRNUSInsmed Reports Inducement Grants Under NASDAQ Listing Rule..
29/7/202414:00PRNUSInsmed to Host Second-Quarter 2024 Financial Results..
10/7/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202414:00PRNUSInsmed Reports Inducement Grants Under NASDAQ Listing Rule..
03/7/202415:03PRNUSAdditional Positive Data from Pivotal ASPEN Study of..
27/6/202414:00PRNUSInsmed Announces Redemption of all $225 Million of..
13/6/202414:00EDGAR2Form 8-K - Current report
12/6/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202414:00PRNUSInsmed Reports Inducement Grants Under NASDAQ Listing Rule..
05/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202414:00PRNUSInsmed To Present at the Goldman Sachs 45th Annual Global..
04/6/202413:00EDGAR2Form 8-K - Current report
03/6/202422:33EDGAR2Form 144 - Report of proposed sale of securities
30/5/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202423:32EDGAR2Form 8-K - Current report
30/5/202422:15EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 72,93 Min: 70,935 Max: 74,09
Chiusura: 72,67

La tua Cronologia

NASDAQ
INSM
Insmed
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network